Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Is Apple Inc. (AAPL) Best Virtual Reality Stock To Buy Now?

We recently published a list of 10 Best Virtual Reality Stocks To Buy Now. In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other best virtual reality stocks.

Overview of the Global VR Market 

Virtual Reality is a computer-generated simulation that allows users to interact with a three-dimensional environment. The four elements that characterize virtual reality and differentiate it from other technologies such as augmented reality and mixed reality are a 3D-simulated environment, immersion, sensory engagement, and realistic interactivity, as revealed by HP.

According to a report by Fortune Business Insights, the global virtual reality market size was valued at $25.11 billion in 2023 and is expected to grow from $32.64 billion in 2024 to $244.84 billion by 2032, at a compound annual growth rate of 28.6% during the forecast period (2024-2032).

Region-wise, North America is expected to dominate the global VR market over the forecast period. Another rapidly growing region is Asia Pacific with growth driven by the rising demand for immersive technologies in emerging economies. China, one of the major distributors of head-mounted VR devices and other hardware, is forecasted to have the highest market share in the region. Simultaneously, Europe is the early adopter of virtual solutions in the automotive industry and will be experiencing significant growth, with Germany and the UK as its leading markets.

How is Virtual Reality Transforming Today’s World?

The virtual reality devices used today have their foundation laid on the first head-mounted augmented reality display “The Sword of Damocles” which was introduced by Ivan Sutherland in 1968. While firms such as Sega and Nintendo developed VR gaming systems in the 1980s and 1990s, it was not until the 2010s that high-quality VR headsets boasting powerful graphics and motion-tracking technology came to the market.

While gaming has been driving the popularity of VR, the potential of the technology has been realized in a multitude of other industries. The American shipping company UPS committed to millions for the advanced training of its drivers, with the firm’s industry-leading training powered by the use of virtual reality in an industrial training environment. Before drivers operate an actual delivery vehicle, the company’s Driving Simulator provides realistic driving experiences.

Virtual reality and augmented reality have also penetrated the healthcare sector as they offer transformative opportunities for medical training, patient care, and therapeutic interventions. The treatment domains in which these technologies are used to treat patients are diverse and include pediatric diagnostics and treatments, pain management, mental health, neurological disorders, surgery planning, intraoperative procedures, telemedicine, as well as post-operative and other rehabilitation therapies. The penetration is evident from the fact that the US FDA has authorized 69 medical devices that incorporate augmented reality and virtual reality.

Virtual Reality is also changing the game for the entertainment industry, especially for artists. Fortnite witnessed a record turnout of more than 12 million attendees to its virtual concert featuring the hip-hop superstar Travis Scott in 2020. Therefore, VR applications continue to spread around today’s world. The renowned luxury car manufacturer BMW has materialized virtual reality experiences in the automotive space. The company expanded its revolutionary driving experience with BMW M Mixed Reality which tends to blur the boundaries between the physical and virtual worlds through state-of-the-art VR/MR technologies.

An Apple store displaying the latest in consumer electronics, from smartphones to wearables.

Our Methodology

In order to compile a list of the 10 best virtual reality stocks to buy now, we utilized stock screeners, ETFs, and online rankings to make an extended list of the relevant companies with the highest market caps. Moving on, we shortlisted the top 10 stocks from our list which had the highest number of hedge fund holders. The 10 best virtual reality stocks to buy now have been arranged in ascending order of their hedge fund holders, as of Q2 2024.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Apple Inc. (NASDAQ:AAPL)

Number of Hedge Fund Holders: 184

The tech giant Apple Inc. (NASDAQ:AAPL) leads the world in innovation with the iPhone, iPad, Mac, AirPods, Apple Watch, and Apple Vision Pro. While the firm is well-reputed for multiple smart devices, it made its entry into VR with the launch of its revolutionary Vision Pro headset at its annual WWDC event in June 2023. Apple Vision Pro extends the experience of one’s go‑to apps and creates new possibilities in entertainment, productivity, gaming, and more.

Apple Vision Pro marked a major development in the VR world as emphasized by top industry executives. The CEO of Taiwanese tech giant HTC Cher Wang saw Apple’s aforementioned move as a validation for the industry and something that would bring more confidence in the global market for VR. Simultaneously, the chief technology officer of Finnish mixed reality startup Varjo Urho Konttori stated:

“Apple’s entrance into XR with Vision Pro is an important moment for our whole industry”

Recently, rumors have revealed that the tech giant is working on an affordable version of Vision Pro mixed reality headset. Apple analyst Ming-Chi Kuo claimed that Apple has delayed the production of the cheaper Vision Pro to beyond 2027. However, Apple is reportedly working on an updated version of the Vision Pro with an upgraded M5 processor to be launched in 2025.

For its fiscal 2024 fourth quarter ended September 28, Apple Inc. (NASDAQ:AAPL) reported revenue of $94.9 billion, a record September quarter revenue driven by iPhone. Apple CEO Tim Cook told CNBC’s Steve Kovach that the sales of the iPhone 15 were stronger than 14 in the year-ago quarter and 16 was stronger than 15. Additionally, Apple’s active installed base of devices reached a new all-time high across all products and all geographic segments. During the quarter, the firm was excited to announce the all-new iPhone 16 lineup, Apple Watch Series 10, and AirPods 4.

Apple Inc. (NASDAQ:AAPL) is a leading VR stock held by 184 hedge funds, as of Q2. The firm has been leading the way in innovation with strong fundamentals and material results.

Overall, AAPL ranks 3rd on our list of  best virtual reality stocks to buy now. While we acknowledge the potential of AAPL as an investment, our conviction lies in the belief that some deeply undervalued AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a deeply undervalued AI stock that is more promising than AAPL but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…